Cupid Limited Stock: price and insider trades · India
1 insider bought shares over the last 90 days, the latest by Aditya Kumar Halwasiya, filed 25 Aug 2026.
Cupid Limited: what insiders have been doing
Cupid Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). Over the twelve months to 26 October 2026, 5 filings were filed, from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 5 purchases, made by 1 insider. The amount is not disclosed for 5 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 major shareholder among the declarants.
The latest purchase dates back some time: it was published 75 days ago, on 25 August 2026. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (1,891 companies, median 4 filings), a count of 5 filings is above the norm. Over the whole record (from 2023), the tally stands at 11 purchases and 27 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +46.0%Entry ₹188.30 · Close at T+90 ₹274.87
- +306.6%Entry ₹16.58 · Close at T+365 ₹67.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,100,000 shares-MarketSEBI:294bc26ff9d1ba052091cef6ca4a9825ad8935a4Canonical exit: 23 Nov 2026 (T+90)
- 803,000 shares-MarketSEBI:eedd964bd525ec2b9c0167062e4fc32c5e8e7fafCanonical exit: 23 Nov 2026 (T+90)
- 1,395,538 shares-MarketSEBI:764ecd5776272dc3a11a4a5ae9fdfaebf5f2149fCanonical exit: 23 Nov 2026 (T+90)
- 2,600,000 shares-MarketSEBI:8a0c13059e4aa05e06824c1a2f8583de713b0b56Canonical exit: 23 Sept 2026 (T+90)
- 2,100,000 shares-MarketSEBI:678fd7e85a2beaebd4684ccac94f29a443d4c8c6Canonical exit: 23 Sept 2026 (T+90)
- 70,000 shares@ ₹7.00100.0% of flowEquity SharesSEBI:45b2cfc37082330ea01c20a5996b4964a1165a76
- 87,172 shares@ ₹82.041.3% of flowEquity SharesSEBI:5abcd662c47c2924b60ebe5c7ef33e7ce068dfba
- 58,678 shares@ ₹83.200.9% of flowEquity SharesSEBI:8d5e774758cef20dd60385e6fea2c5fe0bdfc408
- 2,000 shares@ ₹82.000.0% of flowEquity SharesSEBI:0ea5a7d0a1e25600b8955f12d4730e74655d5ac0
- 4,000 shares@ ₹85.350.1% of flowEquity SharesSEBI:f98f4f6a56a175635e34b7cc58fd701956993ded
- 96,000 shares@ ₹85.161.6% of flowEquity SharesSEBI:d60a54ffb2858c4dd40d9414d700bbefa646732d
- 505,000 shares@ ₹84.091918.8% of flowEquity SharesSEBI:57ca6a8e9fd163e1320a0304cc8ca2158fce7d16Canonical exit: 17 Feb 2025 (T+90)
- 8,821 shares@ ₹83.04150.3% of flowEquity SharesSEBI:b651d04385b71a71310f327717f85d11c3db09acCanonical exit: 16 Feb 2025 (T+90)
- 16,401 shares@ ₹83.0190.6% of flowEquity SharesSEBI:45b84fc6f2a00f6a82a3defbc90f1bd8304578f2Canonical exit: 16 Feb 2025 (T+90)
- 25,000 shares@ ₹85.03238.2% of flowEquity SharesSEBI:54473e9f4f9df5d03b4dadf942c10bcbd33c37e2
- 25,000 shares@ ₹84.87028.2% of flowEquity SharesSEBI:ed60229b82086f314ccb3fa1d7782934ad6ab8b2
- 30,000 shares@ ₹84.879.8% of flowEquity SharesSEBI:ffdb10dd979a7d61e2c259a9e22c36d1c203f332
- 1,460,000 shares@ ₹86.72353.9% of flowEquity SharesSEBI:5afb62f88ebb4dab55b388bc9ab460c4d15bc08eCanonical exit: 17 Dec 2024 (T+90)
- 325,000 shares@ ₹85.042111.7% of flowEquity SharesSEBI:dc220cff2d75cf6092e940c54908801fde8c96d2Canonical exit: 15 Dec 2024 (T+90)
- 400,000 shares@ ₹85.542314.6% of flowEquity SharesSEBI:ac153329ef127afd1228b425256b6cca4e039bceCanonical exit: 12 Dec 2024 (T+90)
- 30,000 shares@ ₹95.138211.4% of flowEquity SharesSEBI:c6699d9b2106d1993e976f38db0f23dd27613962
- 10,000 shares@ ₹93.34263.7% of flowEquity SharesSEBI:b30c01adb079d18f2060ae8e45ae9ab2b6467c56
- 10,000 shares@ ₹93.1517.8% of flowEquity SharesSEBI:0478c3236da537ba7442b1fc14f09aaaeb2da8c1
- 10,000 shares@ ₹99.3518.9% of flowEquity SharesSEBI:f370da0afbe38d6f475520d87921dc7d99d87bba
- 19,000 shares@ ₹120.81149.2% of flowEquity SharesSEBI:084d8632a00ceac44c2efc90bdb4faec63f2b249
25 of 45 declarations
About Cupid Limited
Cupid Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
